Evotec and Variant Bio Partner to Discover and Develop Fibrosis Treatments
The Hamburg headquartered publicly listed drug discovery and development company Evotec and Variant Bio, a US-based biotech company leveraging the
Read more
R&D
NIH Researchers Improve Cancer Drug Response Prediction Using scRNA-seq Data AI Model
In a proof-of-concept study, researchers at the National Institutes of Health (NIH) explored the feasibility of employing transfer learning, a machine
Read more
AbbVie and Medincell Enter Long-acting Injectables (LAI) Deal Worth up to $1.9B
French biotech Medincell announced on Tuesday entering into a collaboration with AbbVie, to co-develop up to six innovative long-acting injectable
Read more
Encouraging Outcomes for Novel Therapy Targeting Drug-resistant Tuberculosis
Researchers have made a significant leap forward in the fight against drug-resistant tuberculosis (TB), according to a recent study published in
Read more
Cutting-Edge Laser Microdissection Advancements – Video
MMI has introduced the next generation of laser microdissection systems – the CellCut. Breakthrough Advancements for Clean and Precise Dissection This
Read more
Machine Learning Tissue Classifiers Power AI in Clinical Research
Machine learning tissue classifiers are one of the most powerful and promising AI-based clinical research solutions for all types of
Read more
Genentech and NVIDIA Join Forces for AI-Powered Drug Discovery
American biotechnology corporation Genentech, a key player in research and early drug development and a subsidiary of the Roche Group,
Read more
StressMarq and OrganoTherapeutics Collaborate to Further Parkinson’s Disease Research
StressMarq Biosciences, a pioneer in the development and commercialization of unique fibrilized and oligomeric protein preparations to propel the study
Read more
StressMarq and Gubra Generate 3D Whole-brain Imaging Model Depicting Alpha-synuclein
A collaboration between StressMarq Biosciences and Gubra has generated a 3D whole-brain light sheet fluorescence imaging model depicting alpha-synuclein pSer129+
Read more
Merck KGaA to Become the First CTDMO Offering Fully Integrated mRNA Services
In a significant milestone for the pharmaceutical industry, Merck KGaA has established itself as the pioneer Contract Testing, Development, and
Read more